Marianne Kjalke

Scientific Director, Rare Blood Disorders, Rare Disease Research
Novo Nordisk A/S, Måløv, Denmark
Måløv, Hovedstaden, Denmark

Presentation(s):

• PB0255 - Comparison of FVIII and concizumab in thrombin generation assays under different conditions

  Sunday, June 23, 2024
  13:45 – 14:45 ICT